Crossmark

MYOD1-mutant spindle cell and sclerosing rhabdomyosarcoma: an aggressive subtype irrespective of age. A reappraisal for molecular classification and risk stratification

Crossref DOI link: https://doi.org/10.1038/s41379-018-0120-9

Published Print: 2019-01

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Agaram, Narasimhan P.

LaQuaglia, Michael P.

Alaggio, Rita

Zhang, Lei

Fujisawa, Yumi

Ladanyi, Marc

Wexler, Leonard H.

Antonescu, Cristina R.
Funding

Funding for this research was provided by:

U.S. Department of Health & Human Services | NIH | National Cancer Institute (PO1 CA047179-15A2, P50 CA 140146-01)
License Information

Text and Data Mining valid from 2019-01-01

Version of Record valid from 2023-01-11
More Information

This article is maintained by: Elsevier

Article Title: MYOD1-mutant spindle cell and sclerosing rhabdomyosarcoma: an aggressive subtype irrespective of age. A reappraisal for molecular classification and risk stratification

Journal Title: Modern Pathology

CrossRef DOI link to publisher maintained version: https://doi.org/10.1038/s41379-018-0120-9

Content Type: article

Copyright: © 2018 United States & Canadian Academy of Pathology.

Document is current

Any future updates will be listed below